SANDRA EDWARDS: Open Payments
NPI 1609451632 · CRESTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 37 payments from 8 companies in 2025. Trend: 2023 $1,007 · 2024 $630 · 2025 $1,205
Food & beverage: $1,201Education: $4
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $299 |
| Alkermes, Inc. | 10 | $245 |
| Boston Scientific Corporation | 11 | $213 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $137 |
| Vanda Pharmaceuticals Inc. | 2 | $129 |
| MDD US Operations, LLC | 1 | $119 |
| ABBVIE INC. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
Products named: WATCHMAN Access System, REXULTI, CAPLYTA, FANAPT, LYBALVI, Qelbree, ARISTADA, ABILIFY MAINTENA.
Industry payments across IA — which companies pay providers there.
